Aki, A., Tanaka, K., Nagaoka, N., Kimura, T., Baba, D., Onodera, Y., . . . Komai, T. (2020). Anti‐ORAI1 antibody DS‐2741a, a specific CRAC channel blocker, shows ideal therapeutic profiles for allergic disease via suppression of aberrant T‐cell and mast cell activation. FASEB Bioadv.
Citación estilo ChicagoAki, Anri, et al. "Anti‐ORAI1 Antibody DS‐2741a, a Specific CRAC Channel Blocker, Shows Ideal Therapeutic Profiles for Allergic Disease Via Suppression of Aberrant T‐cell and Mast Cell Activation." FASEB Bioadv 2020.
Cita MLAAki, Anri, et al. "Anti‐ORAI1 Antibody DS‐2741a, a Specific CRAC Channel Blocker, Shows Ideal Therapeutic Profiles for Allergic Disease Via Suppression of Aberrant T‐cell and Mast Cell Activation." FASEB Bioadv 2020.